For generations of Americans the Johnson & Johnson brand has been a beloved one, as quintessentially American as baseball and ...

Johnson & Johnson is a dividend king stock whose strong product line and consistency has earned it a listing on the Dow Jones ...

Bonuses across almost all of Wall Street are on pace to be lower this year as bankers grapple with tariff-related uncertainty ...

Bonuses in equity underwriting are predicted to plunge up to 20% as firms in the initial public offering market take a “wait ...

With a market cap of $372.9 billion, Johnson & Johnson (JNJ) is a global healthcare leader with a robust and diversified business model spanning pharmaceuticals, medical technologies, and consumer ...